Blocking MAPK/ERK pathway sensitizes hepatocellular carcinoma cells to temozolomide via downregulating MGMT expression

BACKGROUND: Hepatocellular carcinoma (HCC) is the fourth most common malignant tumor in China. Temozolomide (TMZ) is a common chemotherapy drug which can effectively kill HCC cells in vitro. However, it is possible that HCC cells possess intrinsic resistance to TMZ. A key mechanism of TMZ resistance...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Qiang, Ren, Bingjie, Gui, Qi, Zhao, Jing, Wu, Mengyao, Shen, Meng, Li, Dapeng, Li, Daoming, Chen, Kai, Tao, Min, Liang, Rongrui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661899/
https://www.ncbi.nlm.nih.gov/pubmed/33209885
http://dx.doi.org/10.21037/atm-20-5478

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7661899/
https://www.ncbi.nlm.nih.gov/pubmed/33209885
http://dx.doi.org/10.21037/atm-20-5478

Ejemplares similares